Intermittent versus continuous systemic therapy as treatment for unresectable metastatic colorectal cancer

To assess the effect of intermittent systemic therapy versus continuous systemic therapy in terms of survival, toxicity and quality of life in patients with unresectable metastatic colorectal cancer (CRC).

This is a protocol.